Ascentage Pharma Group International American Depository Shares (AAPG) News
NASDAQ: AAPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.97-0.47 (-3.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AAPG news summary
We found 4 recent headlines mentioning Ascentage Pharma Group International American Depository Shares (AAPG): 1 in the past week and 3 in the past 30 days, most often from GlobeNewswire. For price context, AAPG is down 3.78% at $11.97. The most recent story, "Ascentage Pharma Announces Inclusion of Lisaftoclax in China's 2026 National Reimbursement Drug List and Successful Renewal of Coverage for Olverembatinib", was published by GlobeNewswire on Nov 15, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Ascentage Pharma Group International American Depository Shares headlines
- Ascentage Pharma Announces Inclusion of Lisaftoclax in China's 2026 National Reimbursement Drug List and Successful Renewal of Coverage for OlverembatinibROCKVILLE, Md., Nov. 15, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the…GlobeNewswire
- Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026ROCKVILLE, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the…GlobeNewswire
- Ascentage Pharma to Participate in Two Upcoming Investor Conferences in LondonInvestor Conference participationGlobeNewswire
- Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLLLisa granted breakthrough designation for Lisa in ChinaGlobeNewswire